Hodgkin lymphoma (HL) survivors have an increased morbidity and mortality from secondary cancers and cardiovascular disease (CD). We evaluate doses with involved node radiotherapy (INRT) delivered as 3D conformal radiotherapy (3D CRT), volumetric modulated arc therapy (VMAT), or proton therapy (PT), compared with the extensive Mantle Field (MF).
|Journal||Annals of oncology : official journal of the European Society for Medical Oncology / ESMO|
|Number of pages||6|
|Publication status||Published - 24 Aug 2013|